CLINICAL_TRIALS
trial_result
· 2015-11-11
Clinical Trial Update: Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy [Phase 2]
Summary
A Phase 2 study evaluating maintenance sorafenib in patients with small cell lung cancer after response to induction chemotherapy has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Center, Korea | Conditions: Small Cell Lung Cancer | Phase 2 | Status: TERMINATED